![logo](/logos/PROF.webp)
Profound Medical Corp.
NASDAQ:PROF
8.2 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Profound Medical Corp. |
Symbool | PROF |
Munteenheid | USD |
Prijs | 8.2 |
Beurswaarde | 200,750,760 |
Dividendpercentage | 0% |
52-weken bereik | 7.11 - 11.69 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Dr. Arun Swarup Menawat MBA, Ph.D. |
Website | https://www.profoundmedical.com |
An error occurred while fetching data.
Over Profound Medical Corp.
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)